Spectra Plasmonics
Signal active
Organization
Contact Information
Overview
Spectra Plasmonics provides portable technology that offers chemical sensing products. Their core technology is Amplifi ID, which enables chemical analysis without complex lab steps. It offers an optimal, high-performance drug checking solution. They provide software that generates a report for each scanned drug about the detected sample contents.
About
Industries
Biotechnology, Health Care, Medical, Nanotechnology
Founded
2017
Employees
1-10
Headquarters locations
North America
Social
N/A
Profile Resume
Spectra Plasmonics headquartered in North America, operates in the Biotechnology, Health Care, Medical, Nanotechnology sector. The company focuses on Biotechnology and has secured $5.2M in funding across 48 round(s). With a team of 1-10 employees, Spectra Plasmonics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Spectra Plasmonics, raised $15.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$107.9K
Details
0
Spectra Plasmonics has raised a total of $107.9K in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Spectra Plasmonics is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Spectra Plasmonics | - | FUNDING ROUND - Spectra Plasmonics | undefined |
| Capital Angel Network | - | FUNDING ROUND - Capital Angel Network | undefined |
| Spectra Plasmonics | - | FUNDING ROUND - Spectra Plasmonics | 15.0K |
| Queen's University | - | FUNDING ROUND - Queen's University | 15.0K |
Recent Activity
There is no recent news or activity for this profile.